IM Cannabis Reports Record Second Quarter 2022 Financial Results; Revenues Increase 114% YoY to $23.8 Million Gross margin of 24%, which is expected to increase with further asset integration,...

IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million Gross Profit Increased 37% from Q1 2021 as Operational Efficiencies from Integration Take...

IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel Q2 2021 revenues of $11.1 million,...